Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II first-line GEMOX in T-cell non-Hodgkin lymphoma
2004-004675-11Phase 2Terminated
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Mar 2006
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of gemcitabine and oxaliplatin in non-Hodgkin lymphoma, T-cell, sponsored by Sant'Orsola-Malpighi University Hospital. Started Mar 2006; status: terminated.
02
Drugs
gemcitabineoxaliplatin
03
Conditions
non-Hodgkin lymphoma, T-cell
Beyond the preview
Go deeper on 2004-004675-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004675-11.